KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Twist Bioscience (TWST) Accumulated Depreciation & Amortization: 2018-2025

Historic Accumulated Depreciation & Amortization for Twist Bioscience (TWST) over the last 4 years, with Sep 2025 value amounting to $6.0 million.

  • Twist Bioscience's Accumulated Depreciation & Amortization fell 9.80% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.9 million, marking a year-over-year decrease of 20.93%. This contributed to the annual value of $24.9 million for FY2025, which is 20.93% down from last year.
  • Twist Bioscience's Accumulated Depreciation & Amortization amounted to $6.0 million in Q3 2025, which was down 1.01% from $6.1 million recorded in Q2 2025.
  • Twist Bioscience's Accumulated Depreciation & Amortization's 5-year high stood at $35.4 million during Q3 2021, with a 5-year trough of $3.1 million in Q4 2021.
  • In the last 3 years, Twist Bioscience's Accumulated Depreciation & Amortization had a median value of $7.0 million in 2023 and averaged $7.3 million.
  • As far as peak fluctuations go, Twist Bioscience's Accumulated Depreciation & Amortization crashed by 86.02% in 2022, and later skyrocketed by 91.04% in 2023.
  • Twist Bioscience's Accumulated Depreciation & Amortization (Quarterly) stood at $3.1 million in 2021, then surged by 68.00% to $5.3 million in 2022, then soared by 54.40% to $8.2 million in 2023, then fell by 21.92% to $6.4 million in 2024, then declined by 9.80% to $6.0 million in 2025.
  • Its Accumulated Depreciation & Amortization was $6.0 million in Q3 2025, compared to $6.1 million in Q2 2025 and $6.4 million in Q1 2025.